SynthesisLung cancer (Amsterdam, Netherlands)2016

The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials.

Bob T Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.